Australian drug exporters are cautiously optimistic as US President Trump announces 100% tariffs on pharmaceuticals, with Health Minister Mark Butler stating the impact on the sector remains uncertain. The Federal Government is assessing whether major exporter CSL will be exempt, while companies with US market exposure are monitoring the situation closely.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
